KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Times Interest Earned (2018 - 2025)

TherapeuticsMD filings provide 12 years of Times Interest Earned readings, the most recent being -$287.33 for Q3 2025.

  • On a quarterly basis, Times Interest Earned rose 23.99% to -$287.33 in Q3 2025 year-over-year; TTM through Mar 2026 was -$766.4, a 30.87% decrease, with the full-year FY2021 number at -$3.53, up 40.95% from a year prior.
  • Times Interest Earned hit -$287.33 in Q3 2025 for TherapeuticsMD, up from -$347.5 in the prior quarter.
  • In the past five years, Times Interest Earned ranged from a high of -$1.24 in Q1 2022 to a low of -$640.5 in Q1 2025.
  • Median Times Interest Earned over the past 5 years was -$54.93 (2023), compared with a mean of -$186.98.
  • Biggest five-year swings in Times Interest Earned: skyrocketed 64.8% in 2021 and later plummeted 4200.62% in 2023.
  • TherapeuticsMD's Times Interest Earned stood at -$6.56 in 2021, then surged by 81.1% to -$1.24 in 2022, then crashed by 7047.55% to -$88.65 in 2023, then tumbled by 326.4% to -$378.0 in 2024, then rose by 23.99% to -$287.33 in 2025.
  • The last three reported values for Times Interest Earned were -$287.33 (Q3 2025), -$347.5 (Q2 2025), and -$640.5 (Q1 2025) per Business Quant data.